You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
澳洲計劃自10月起 減少供應阿斯利康疫苗
阿思達克 06-24 11:39
澳洲公佈,因應現時新冠疫苗分配和接種情況,包括各款疫苗會於年底有充足供應,以及市民對各款疫苗需求,計劃自10月起,下調阿斯利康的供應數字。

文件顯示,7月及8月,阿斯利康仍會維持每週約260萬劑的供應,但自10月起,將會改爲根據要求提供。至於莫德納疫苗,則會自9月起,每週有12.5萬劑供應。而輝瑞疫苗的供應會由7-8月的每週75萬劑,增至130萬劑,至年底更可增至170萬至230萬劑,屆時將足夠全民的使用量。

由於此前在當地發現多例由阿斯利康疫苗引發血栓甚至導致死亡的案例,衛生部僅建議60歲及以上年齡的居民接種阿斯利康疫苗。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account